Insider filing · ANTX
AN2 Therapeutics, Inc.
ANTX · Healthcare · 3 filings in 24 months
ticker →
Braden Michael Leonard sold $2.9M of AN2 Therapeutics (ANTX)
Executed May 28 2025, disclosed May 30 2025, 2 days later.
Value, as filed
$2.9M
2,525,000 sh across 3 lots
Executed
May 28 2025
the trade date, as filed
Disclosed
May 30 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
BL
Braden Michael Leonard
10% owner
profile →
Braden Michael Leonard (10% owner) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in ADVM. The largest single filing was $2.4M of ADVM (574,886 sh across 3 lots, as filed), executed Dec 1 2025.
The name
ANTXHealthcare · AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Braden Michael Leonard in ANTX
ANTXSALE
AN2 Therapeutics, Inc.
$218K200,000 sh × $1.09
Exec May 28 2025
Filed Jun 16 2025 · 5:30 PM ET †